Skip to main content
Premium Trial:

Request an Annual Quote

Agilix Licenses Proteomics Labeling Technology to Protana

NEW YORK, July 21 (GenomeWeb News) - Protana has taken a license to Agilix' protein labeling technology for proteomics, New Haven, Conn.-based Agilix said today.

 

Under the non-exclusive license, Protana will offer Agilix's i-Prot technology as part of its proteomic services. The companies did not disclose the terms of the agreement. According to Agilix, i-Prot allows researchers to measure many labels simultaneously.

 

Protana emerged from the ailing MDS Proteomics a year ago.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more